Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lara Felicioni

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Pathologica|April 28, 2023
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case reportFiamma Buttitta, Pietro Di Marino, Lara Felicioni, et al.
Neoplasia (New York, N.Y.)|September 24, 2014
Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancerGiampietro Gasparini, Fiamma Buttitta, Mario Rosario D'Andrea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatmentAntonio Marchetti, Carla Martella, Lara Felicioni, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2002
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluationAntonio Marchetti, Caterina Pellegrini, Fiamma Buttitta, et al.
Pathologica|May 22, 2023
POLE exonuclease domain mutations in endometrial carcinoma: a case reportMaria Paola Pasciuto, Lara Felicioni, Claudia Zampacorta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Int6 expression can predict survival in early-stage non-small cell lung cancer patientsFiamma Buttitta, Carla Martella, Fabio Barassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2012
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencingFiamma Buttitta, Lara Felicioni, Maela Del Grammastro, et al.
Journal of Clinical Pathology|October 6, 2020
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS NetworkCaterina Fumagalli, Elena Guerini-Rocco, Fiamma Buttitta, et al.
Human Mutation|February 23, 2008
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungAntonio Marchetti, Lara Felicioni, Giuseppe Pelosi, et al.
Stroke|August 6, 2011
A unique microRNA signature associated with plaque instability in humansFrancesco Cipollone, Lara Felicioni, Riccardo Sarzani, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Pathologica|April 28, 2023
BRCA gene amplification in primary peritoneal high-grade serous carcinoma patient with intrinsic resistance to platinum treatment: a case reportFiamma Buttitta, Pietro Di Marino, Lara Felicioni, et al.
Neoplasia (New York, N.Y.)|September 24, 2014
Optimizing single agent panitumumab therapy in pre-treated advanced colorectal cancerGiampietro Gasparini, Fiamma Buttitta, Mario Rosario D'Andrea, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatmentAntonio Marchetti, Carla Martella, Lara Felicioni, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 18, 2002
Prediction of survival in stage I lung carcinoma patients by telomerase function evaluationAntonio Marchetti, Caterina Pellegrini, Fiamma Buttitta, et al.
Pathologica|May 22, 2023
POLE exonuclease domain mutations in endometrial carcinoma: a case reportMaria Paola Pasciuto, Lara Felicioni, Claudia Zampacorta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Int6 expression can predict survival in early-stage non-small cell lung cancer patientsFiamma Buttitta, Carla Martella, Fabio Barassi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2012
Effective assessment of egfr mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencingFiamma Buttitta, Lara Felicioni, Maela Del Grammastro, et al.
Journal of Clinical Pathology|October 6, 2020
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS NetworkCaterina Fumagalli, Elena Guerini-Rocco, Fiamma Buttitta, et al.
Human Mutation|February 23, 2008
Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungAntonio Marchetti, Lara Felicioni, Giuseppe Pelosi, et al.
Stroke|August 6, 2011
A unique microRNA signature associated with plaque instability in humansFrancesco Cipollone, Lara Felicioni, Riccardo Sarzani, et al.
Pageof 4